Skip to main
TBI
TBI logo

TrueBlue (TBI) Stock Forecast & Price Target

TrueBlue (TBI) Analyst Ratings

Based on 1 analyst ratings
Buy
Strong Buy 0%
Buy 100%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

TrueBlue Inc. has demonstrated resilience with a 2% year-over-year revenue increase, primarily bolstered by significant growth in the commercial staffing sector. The company recorded a notable improvement in its adjusted EBITDA margin, rising by 50 basis points to 0.7%, attributed to effective strategic cost measures. This combination of steady revenue growth in key segments and enhanced operational efficiency supports a positive outlook for TrueBlue's stock.

Bears say

TrueBlue Inc. reported a significant decline in its adjusted EBITDA margin, which decreased by 320 basis points year-over-year to 5.2%, reflecting lower operating leverage as organic revenues experienced a downturn. Additionally, the PeopleReady segment, which accounts for the majority of the company’s revenues, saw a revenue decline of 5% year-over-year, exceeding the projected decline of 3%, highlighting persistent weaknesses across various client verticals. Furthermore, TrueBlue reported an adjusted loss per share of $(0.07) for the second quarter, indicating ongoing financial strain and performance issues.

TrueBlue (TBI) has been analyzed by 1 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 100% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of TrueBlue and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About TrueBlue (TBI) Forecast

Analysts have given TrueBlue (TBI) a Buy based on their latest research and market trends.

According to 1 analysts, TrueBlue (TBI) has a Buy consensus rating as of Oct 29, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $8, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $8, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

TrueBlue (TBI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.